Paradigm Genetics Inc.
Paradigm Genetics Inc., Research Triangle Park, N.C., is issued a patent titled "Methods for the Identification of Inhibitors of Alpha-Aminoadipate Reductase as Antibiotics." The patent covers the discovery of a novel gene target (Alpha-Aminoadipate Reductase). Chemical compounds discovered by Paradigm's patented method may lead to the development of more effective, less toxic fungicides. "The issuance of this patent significantly strengthens our intellectual property position on important fungicide target pathways and further demonstrates our ability to apply a systems biology approach to gain a more comprehensive understanding of entire biological systems," says Keith Davis, Ph.D., vice president of Agricultural Research for Paradigm.
|Printer friendly Cite/link Email Feedback|
|Title Annotation:||Marketing News; patent issued|
|Article Type:||Brief Article|
|Date:||Jun 1, 2004|
|Previous Article:||BASF Canada's Agriculture Division selects Quarry Integrated Communications as agency of record after an agency review conducted to consolidate...|
|Next Article:||Beef checkoff.|